Precision Clinical Trial Recruitment to Promote Cancer Health Equity Across Florida

精准临床试验招募促进佛罗里达州癌症健康公平

基本信息

  • 批准号:
    11002204
  • 负责人:
  • 金额:
    $ 68.29万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-09-09 至 2027-08-31
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY Racial and ethnic minorities represent the fastest growing segment of the United States adult population, yet they remain significantly underrepresented in cancer clinical trials (CCTs). Low trust in clinical research and recruitment approaches that fail to address multilevel barriers to CCT participation are key reasons for minority population underrepresentation. Community health educators (CHEs) improve trust in research among underrepresented populations, yet relying on exclusively on CHE availability can limit intervention reach. Virtual CHEs (vCHEs) improve scalability by extending CHE capabilities and capitalizing on remote recruitment techniques. The purpose of the current project is to increase referral of diverse participants to NCI-supported clinical trials via a culturally responsive, multi-level intervention that utilizes vCHEs to reach diverse populations. We will consolidate existing referral channels within the ALEX Research Portal. ALEX offers a custom experience for clinicians, CHEs, and patients to facilitate CCT referrals. Clinicians can utilize the portal to refer to CCTs; CHEs can use the portal to create an avatar that can provide introductory information to patients and schedule video-conference follow-ups; patients, families, and community members can use the portal to easily navigate to key information and make self- and other-referrals. The ability to streamline information to patients and CCT referrals to study coordinators is expected to improve the overall referral to CCTs. The ALEX Research Portal utilizes the adaptive virtual human technology developed at the University of Florida that provides users with culturally and linguistically tailored CCT information. The ALEX Research Portal will be developed and launched across three distinct geographic areas of Florida (Gainesville, Jacksonville, and Miami). This unique collaborative opportunity will provide access to participants representative of the racial and ethnic diversity of the state as well as cancer centers conducting CCTs associated with national networks (ETCTN, NCTN). Guided by the Interactive Systems Framework for dissemination and implementation, our goal is to increase referrals to CCTs by optimizing the ALEX Research Portal for broad use. The outcome will be an evidence-based intervention that can be widely disseminated to quickly increase the referral of diverse patients to CCTs. This project will be conducted in three phases: (Phase I) establish a baseline of referrals and accrual of diverse participants to CCTs across multiple Florida Center Centers, (Phase 2) adapt and pilot the ALEX Research Portal using a randomized controlled clinical trial, and (Phase 3) scale the intervention by dissemination via the OneFlorida network. The proposed study will result in an empirically-tested vCHE Research Portal for increasing trust in CCTs among diverse populations that can easily be adapted and disseminated across the state to overcome challenges associated with recruiting diverse participants to CCTs.
项目摘要 种族和少数民族是美国成年人口中增长最快的部分, 他们在癌症临床试验(CCT)中的代表性仍然显著不足。对临床研究的信任度低, 招聘方法未能解决CCT参与的多层次障碍是少数人的主要原因。 人口代表性不足。社区卫生教育工作者(CHE)提高了对研究的信任, 虽然这类人群代表性不足,但完全依赖卫生保健服务的提供可能会限制干预措施的覆盖面。 虚拟CHE(vCHE)通过扩展CHE功能和利用远程招聘来提高可扩展性 技术.目前项目的目的是增加将不同参与者转介到国家癌症研究所支持的 临床试验,通过文化响应,多层次的干预,利用vCHE,以达到不同的 人口。我们将整合ALEX研究门户网站内的现有转介渠道。ALEX提供 为临床医生、CHE和患者提供定制体验,以促进CCT转诊。临床医生可以利用门户网站 以引用CCT; CHE可以使用门户创建可提供介绍性信息的头像, 患者和安排视频会议随访;患者,家属和社区成员可以使用 门户网站,以轻松地导航到关键信息,并使自我和他人转介。精简的能力 向患者提供信息和向研究协调员提供CCT转诊,预计将改善向 CCT。ALEX研究门户网站利用了自适应虚拟人技术, 佛罗里达,为用户提供文化和语言定制的CCT信息。ALEX研究 门户网站将在佛罗里达的三个不同的地理区域(盖恩斯维尔, 杰克逊维尔和迈阿密)。这一独特的合作机会将为参与者提供 代表国家的种族和民族多样性以及癌症中心进行CCT 与国家网络(ETCTN,NCTN)相关联。在交互式系统框架的指导下, 传播和实施,我们的目标是通过优化ALEX研究, 门户网站广泛使用。其成果将是一项循证干预措施,可广泛传播, 快速增加不同患者到CCT的转诊。该项目将分三个阶段进行: I)建立多个佛罗里达中心CCT的不同参与者的转诊和累积基线 中心,(2期)采用随机对照临床试验调整和试点ALEX研究门户网站,以及 (第三阶段)通过OneFlorida网络传播来扩大干预规模。拟议的研究将导致 一个经过验证的vCHE研究门户网站,用于增加不同人群对CCT的信任, 易于在全州范围内进行调整和传播,以克服与招聘相关的挑战 不同的CCT参与者。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Olveen Carrasquillo其他文献

Olveen Carrasquillo的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Olveen Carrasquillo', 18)}}的其他基金

Miami Clinical and Translational Science Institute
迈阿密临床与转化科学研究所
  • 批准号:
    10708431
  • 财政年份:
    2023
  • 资助金额:
    $ 68.29万
  • 项目类别:
Cardiovascular Research Empowerment Workforce
心血管研究赋权劳动力
  • 批准号:
    10680765
  • 财政年份:
    2023
  • 资助金额:
    $ 68.29万
  • 项目类别:
Precision Clinical Trial Recruitment to Promote Cancer Health Equity Across Florida
精准临床试验招募促进佛罗里达州癌症健康公平
  • 批准号:
    10538749
  • 财政年份:
    2022
  • 资助金额:
    $ 68.29万
  • 项目类别:
Community Engagement Core
社区参与核心
  • 批准号:
    10494164
  • 财政年份:
    2021
  • 资助金额:
    $ 68.29万
  • 项目类别:
Community Engagement Core
社区参与核心
  • 批准号:
    10657763
  • 财政年份:
    2021
  • 资助金额:
    $ 68.29万
  • 项目类别:
Community Engagement Core
社区参与核心
  • 批准号:
    10437312
  • 财政年份:
    2021
  • 资助金额:
    $ 68.29万
  • 项目类别:
Novel, High-Impact Studies Evaluating Health System and Healthcare Professional Responsiveness to COVID-19
评估卫生系统和医疗保健专业人员对 COVID-19 反应的新颖、高影响力研究
  • 批准号:
    10193144
  • 财政年份:
    2020
  • 资助金额:
    $ 68.29万
  • 项目类别:
Novel, High-Impact Studies Evaluating Health System and Healthcare Professional Responsiveness to COVID-19
评估卫生系统和医疗保健专业人员对 COVID-19 反应的新颖、高影响力研究
  • 批准号:
    10310504
  • 财政年份:
    2020
  • 资助金额:
    $ 68.29万
  • 项目类别:
Behavioral and Community-based Shared Resources
行为和社区共享资源
  • 批准号:
    10190859
  • 财政年份:
    2019
  • 资助金额:
    $ 68.29万
  • 项目类别:
Behavioral and Community-based Shared Resources
行为和社区共享资源
  • 批准号:
    10670840
  • 财政年份:
    2019
  • 资助金额:
    $ 68.29万
  • 项目类别:

相似国自然基金

Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data
  • 批准号:
    31070748
  • 批准年份:
    2010
  • 资助金额:
    34.0 万元
  • 项目类别:
    面上项目

相似海外基金

Precision Clinical Trial Recruitment to Promote Cancer Health Equity Across Florida
精准临床试验招募促进佛罗里达州癌症健康公平
  • 批准号:
    10538749
  • 财政年份:
    2022
  • 资助金额:
    $ 68.29万
  • 项目类别:
Decentralising precision medicine patient recruitment and clinical trial research to accelerate drug development
分散精准医学患者招募和临床试验研究以加速药物开发
  • 批准号:
    10034737
  • 财政年份:
    2022
  • 资助金额:
    $ 68.29万
  • 项目类别:
    Collaborative R&D
Mechanistic clinical trial of blocking the IL-4/13 axis in asthmatics precision phenotyped in an aeroallergen challenge chamber before, during and after receipt of dupilumab
在接受 dupilumab 之前、期间和之后在空气过敏原激发室中精确表型的哮喘患者中阻断 IL-4/13 轴的机制临床试验
  • 批准号:
    10686198
  • 财政年份:
    2022
  • 资助金额:
    $ 68.29万
  • 项目类别:
Determining the long-term outcomes and optimal treatment of childhood nephrotic syndrome using population-based administrative health data, target trial emulation, and a pilot adaptive clinical trial of a precision medicine treatment strategy
使用基于人群的管理健康数据、目标试验模拟和精准医学治疗策略的试点适应性临床试验来确定儿童肾病综合征的长期结果和最佳治疗
  • 批准号:
    475537
  • 财政年份:
    2022
  • 资助金额:
    $ 68.29万
  • 项目类别:
    Studentship Programs
Mechanistic clinical trial of blocking the IL-4/13 axis in asthmatics precision phenotyped in an aeroallergen challenge chamber before, during and after receipt of dupilumab
在接受 dupilumab 之前、期间和之后在空气过敏原激发室中精确表型的哮喘患者中阻断 IL-4/13 轴的机制临床试验
  • 批准号:
    10488483
  • 财政年份:
    2022
  • 资助金额:
    $ 68.29万
  • 项目类别:
Evaluating a precision medicine approach to nephrotic syndrome using novel genetic risk profiles: A pilot adaptive clinical trial
使用新的遗传风险特征评估肾病综合征的精准医学方法:一项试点适应性临床试验
  • 批准号:
    466596
  • 财政年份:
    2021
  • 资助金额:
    $ 68.29万
  • 项目类别:
    Studentship Programs
A vascularized patient-derived iPSC liver acinus microphysiology system as an innovative precision medicine platform for optimizing clinical trial design for nonalcoholic fatty liver disease
血管化患者来源的 iPSC 肝腺微生理学系统作为创新精准医学平台,用于优化非酒精性脂肪肝疾病的临床试验设计
  • 批准号:
    10216378
  • 财政年份:
    2020
  • 资助金额:
    $ 68.29万
  • 项目类别:
A vascularized patient-derived iPSC liver acinus microphysiology system as an innovative precision medicine platform for optimizing clinical trial design for nonalcoholic fatty liver disease
血管化患者来源的 iPSC 肝腺微生理学系统作为创新精准医学平台,用于优化非酒精性脂肪肝疾病的临床试验设计
  • 批准号:
    10033652
  • 财政年份:
    2020
  • 资助金额:
    $ 68.29万
  • 项目类别:
A vascularized patient-derived iPSC liver acinus microphysiology system as an innovative precision medicine platform for optimizing clinical trial design for nonalcoholic fatty liver disease
血管化患者来源的 iPSC 肝腺微生理学系统作为创新精准医学平台,用于优化非酒精性脂肪肝疾病的临床试验设计
  • 批准号:
    10651754
  • 财政年份:
    2020
  • 资助金额:
    $ 68.29万
  • 项目类别:
A vascularized patient-derived iPSC liver acinus microphysiology system as an innovative precision medicine platform for optimizing clinical trial design for nonalcoholic fatty liver disease
血管化患者来源的 iPSC 肝腺微生理学系统作为创新精准医学平台,用于优化非酒精性脂肪肝疾病的临床试验设计
  • 批准号:
    10457577
  • 财政年份:
    2020
  • 资助金额:
    $ 68.29万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了